257 related articles for article (PubMed ID: 36982848)
41. Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.
Munkuev AA; Dyrkheeva NS; Kornienko TE; Ilina ES; Ivankin DI; Suslov EV; Korchagina DV; Gatilov YV; Zakharenko AL; Malakhova AA; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2022 May; 27(11):. PubMed ID: 35684313
[TBL] [Abstract][Full Text] [Related]
42. TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy.
Alagoz M; Wells OS; El-Khamisy SF
Nucleic Acids Res; 2014 Mar; 42(5):3089-103. PubMed ID: 24335147
[TBL] [Abstract][Full Text] [Related]
43. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2016 Nov; 24(21):5017-5027. PubMed ID: 27687971
[TBL] [Abstract][Full Text] [Related]
44. Post-translational regulation of Tyrosyl-DNA phosphodiesterase (TDP1 and TDP2) for the repair of the trapped topoisomerase-DNA covalent complex.
Bhattacharjee S; Rehman I; Nandy S; Das BB
DNA Repair (Amst); 2022 Mar; 111():103277. PubMed ID: 35101776
[TBL] [Abstract][Full Text] [Related]
45. PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes.
Rehman I; Basu SM; Das SK; Bhattacharjee S; Ghosh A; Pommier Y; Das BB
Nucleic Acids Res; 2018 Jun; 46(11):5601-5617. PubMed ID: 29718323
[TBL] [Abstract][Full Text] [Related]
46. Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan.
Meisenberg C; Gilbert DC; Chalmers A; Haley V; Gollins S; Ward SE; El-Khamisy SF
Mol Cancer Ther; 2015 Feb; 14(2):575-85. PubMed ID: 25522766
[TBL] [Abstract][Full Text] [Related]
47. [Tyrosyl-DNA Phosphodiesterase 1 Is a New Player in Repair of Apurinic/Apyrimidinic Sites].
Rechkunova NI; Lebedeva NA; Lavrik OI
Bioorg Khim; 2015; 41(5):531-8. PubMed ID: 26762090
[TBL] [Abstract][Full Text] [Related]
48. TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data.
Jakobsen AK; Yuusufi S; Madsen LB; Meldgaard P; Knudsen BR; Stougaard M
Lung Cancer; 2022 Feb; 164():23-32. PubMed ID: 34974222
[TBL] [Abstract][Full Text] [Related]
49. Tdp1 protects from topoisomerase 1-mediated chromosomal breaks in adult zebrafish but is dispensable during larval development.
Zaksauskaite R; Thomas RC; van Eeden F; El-Khamisy SF
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514542
[TBL] [Abstract][Full Text] [Related]
50. TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugs.
Chowdhury SR; Das SK; Banerjee B; Paul Chowdhuri S; Majumder HK; Das BB
FASEB J; 2022 Apr; 36(4):e22265. PubMed ID: 35319800
[TBL] [Abstract][Full Text] [Related]
51. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.
Miao ZH; Agama K; Sordet O; Povirk L; Kohn KW; Pommier Y
DNA Repair (Amst); 2006 Dec; 5(12):1489-94. PubMed ID: 16935573
[TBL] [Abstract][Full Text] [Related]
52. Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison.
He X; van Waardenburg RCAM; Babaoglu K; Price AC; Nitiss KC; Nitiss JL; Bjornsti MA; White SW
J Mol Biol; 2007 Sep; 372(4):1070-1081. PubMed ID: 17707402
[TBL] [Abstract][Full Text] [Related]
53. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.
Barthelmes HU; Habermeyer M; Christensen MO; Mielke C; Interthal H; Pouliot JJ; Boege F; Marko D
J Biol Chem; 2004 Dec; 279(53):55618-25. PubMed ID: 15494395
[TBL] [Abstract][Full Text] [Related]
54. Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.
Walker S; Meisenberg C; Bibby RA; Askwith T; Williams G; Rininsland FH; Pearl LH; Oliver AW; El-Khamisy S; Ward S; Atack JR
Anal Biochem; 2014 Jun; 454(100):17-22. PubMed ID: 24637157
[TBL] [Abstract][Full Text] [Related]
55. The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.
Nikolin VP; Popova NA; Kaledin VI; Luzina OA; Zakharenko AL; Salakhutdinov NF; Lavrik OI
Clin Exp Metastasis; 2021 Oct; 38(5):431-440. PubMed ID: 34370156
[TBL] [Abstract][Full Text] [Related]
56. Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.
Khomenko TM; Zakharenko AL; Chepanova AA; Ilina ES; Zakharova OD; Kaledin VI; Nikolin VP; Popova NA; Korchagina DV; Reynisson J; Chand R; Ayine-Tora DM; Patel J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878088
[TBL] [Abstract][Full Text] [Related]
57. SUMO-targeted ubiquitin ligase, Rad60, and Nse2 SUMO ligase suppress spontaneous Top1-mediated DNA damage and genome instability.
Heideker J; Prudden J; Perry JJ; Tainer JA; Boddy MN
PLoS Genet; 2011 Mar; 7(3):e1001320. PubMed ID: 21408210
[TBL] [Abstract][Full Text] [Related]
58. New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition.
Dyrkheeva NS; Filimonov AS; Luzina OA; Zakharenko AL; Ilina ES; Malakhova AA; Medvedev SP; Reynisson J; Volcho KP; Zakian SM; Salakhutdinov NF; Lavrik OI
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356597
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
[TBL] [Abstract][Full Text] [Related]
60. Tyrosyl-DNA Phosphodiesterase I N-Terminal Domain Modifications and Interactions Regulate Cellular Function.
Brettrager EJ; Segura IA; van Waardenburg RCAM
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
